当前位置:首页 - 行情中心 - 天目药业(600671) - 财务分析 - 现金流量表

天目药业

(600671)

  

流通市值:20.55亿  总市值:20.56亿
流通股本:1.22亿   总股本:1.22亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金193,815,847.98137,547,04539,906,343234,985,355.88
  收到的税费返还---25,081.09
  收到其他与经营活动有关的现金8,221,573.926,361,221.122,525,846.0222,224,324.72
  经营活动现金流入小计202,037,421.9143,908,266.1242,432,189.02257,234,761.69
  购买商品、接受劳务支付的现金106,642,585.6770,053,355.7134,340,825.27148,909,690.64
  支付给职工以及为职工支付的现金33,991,945.9322,816,038.8511,498,161.2942,761,805.27
  支付的各项税费15,158,218.4311,686,366.555,729,674.6624,383,766.02
  支付其他与经营活动有关的现金24,534,070.9615,065,884.0810,293,040.9329,388,350.52
  经营活动现金流出小计180,326,820.99119,621,645.1961,861,702.15245,443,612.45
  经营活动产生的现金流量净额21,710,600.9124,286,620.93-19,429,513.1311,791,149.24
二、投资活动产生的现金流量:
  取得投资收益收到的现金---3,993.35
  处置固定资产、无形资产和其他长期资产收回的现金净额---22,768
  收到的其他与投资活动有关的现金---3,500,001
  投资活动现金流入的平衡项目---0
  投资活动现金流入小计---3,526,762.35
  购建固定资产、无形资产和其他长期资产支付的现金10,055,913.67,583,8173,564,722.0631,176,853.44
  支付其他与投资活动有关的现金---3,500,001
  投资活动现金流出小计10,055,913.67,583,8173,564,722.0634,676,854.44
  投资活动产生的现金流量净额-10,055,913.6-7,583,817-3,564,722.06-31,150,092.09
三、筹资活动产生的现金流量:
  吸收投资收到的现金---1,770,000
  取得借款收到的现金153,767,073.65135,733,973.65102,353,973.65162,136,300
  收到其他与筹资活动有关的现金15,908---
  筹资活动现金流入小计153,782,981.65135,733,973.65102,353,973.65163,906,300
  偿还债务支付的现金153,353,956108,089,15667,547,956144,727,140
  分配股利、利润或偿付利息支付的现金4,353,671.723,129,176.21,560,945.596,497,576.74
  支付其他与筹资活动有关的现金9,245,404.325,024,724.342,292,773.2514,509,984.09
  筹资活动现金流出小计166,953,032.04116,243,056.5471,401,674.84165,734,700.83
  筹资活动产生的现金流量净额-13,170,050.3919,490,917.1130,952,298.81-1,828,400.83
五、现金及现金等价物净增加额-1,515,363.0836,193,721.047,958,063.62-21,187,343.68
  加:期初现金及现金等价物余额26,276,647.7926,276,647.7926,276,647.7947,463,991.47
  期末现金及现金等价物余额24,761,284.7162,470,368.8334,234,711.4126,276,647.79
补充资料:
  净利润-4,941,350.57-7,202,945.17
  资产减值准备-60,200.18-1,657,052.82
  固定资产和投资性房地产折旧-7,197,546.98-14,301,112.85
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-7,197,546.98-14,301,112.85
  无形资产摊销-83,059.5-162,343.23
  长期待摊费用摊销-1,056,759.1-12,547,863.05
  处置固定资产、无形资产和其他长期资产的损失-6,396.08-11,714.52
  固定资产报废损失-220.51--241,401.25
  财务费用-3,376,624.56-7,198,209.47
  投资损失-5,590.28-1,708,564.94
  递延所得税--212,410.11--913,929.07
  其中:递延所得税资产减少-1,099,478.02--2,728,045.01
    递延所得税负债增加--1,311,888.13-1,814,115.94
  存货的减少-134,145.52-13,138,461.14
  经营性应收项目的减少-21,015,219.17--50,116,344.22
  经营性应付项目的增加--19,587,375.95--7,135,831.09
  融资租入固定资产---20,922,923.65
  现金的期末余额-62,470,368.83-26,276,647.79
  减:现金的期初余额-26,276,647.79-47,463,991.47
  现金及现金等价物的净增加额-36,193,721.04--21,187,343.68
公告日期2026-10-312026-08-282026-04-302026-04-18
审计意见(境内)标准无保留意见
TOP↑